Over 500 million euros in local production capacity
Investment in Health
1.5% contribution to GDP
The best solution at the best price
Research & Development
APMGR welcomes the launch of the IMS Health report "The role of generic medicines in sustaining healthcare systems: a European perspective" which highlights that generic medicines competition has almost doubled the access to medicines across seven key therapy areas. Without generic medicines, healthcare systems and patients would have had to pay an estimated additional 100 billion Euros in 2014. The new report was presented at the EGA annual conference and can be accessed in full here.
Medicines for Europe Association adopted a Code of Conduct for the European generic and biosimilar medicines industries that strengthens its commitment to set strong ethical standards and secure trustworthy and transparent relations between the industry and the healthcare community. You can check the Code here.
INFOGRAPHIC Clawback Tax: how to apply and what is the impact on the producers of generic medicines. Access the infographic here.
About Generic Drug Manufacturers Association in Romania.
APMGR gathers the most important companies from generic medicine manufacturing present on Romanian companies: Actavis, Alvogen Romania, Accord Healthcare, Biofarm, Cipla, Dr. Reddy’s, Egis, Fresenius Kabi, Gedeon Richter, Infomed Fluids, Krka, Magistra CC, Medochemie, Sandoz, Terapia - a Sun Pharma company, Teva, Zentiva